Chargement de la fiche…
Chargement de la fiche…

Photo : FL2014, CC BY-SA 4.0, Wikimedia Commons
Vous êtes Dre Julie Hernandez ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dre Julie Hernandez est rhumatologue à Montauban (82000). Elle consulte à CABINET DU DR JULIE HERNANDEZ, CABINET MEDICAL BELLEVUE — 330 AVENUE CHARLES DE GAULLE, 82000 Montauban. Elle accepte la carte Vitale.
Consulter
CABINET DU DR JULIE HERNANDEZ
CABINET MEDICAL BELLEVUE — 330 AVENUE CHARLES DE GAULLE, 82000 Montauban
Libéral
Dre Julie Hernandez, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DIU Etudes approfondies polyarthrites-maladies · DE Docteur en médecine — Capacité / certificat d'études spéciales
DIU Études approfondies polyarthrites & maladies auto-immunes
Le DIU rhumato généraliste de référence : polyarthrite rhumatoïde, spondyloarthrite, lupus, Sjögren, vascularites. Coordonné par la SFR.
Plusieurs universités, coordination Société Française de Rhumatologie (SFR)
Les plus citées
2019Stem cell research & therapy119 citations
Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer
2020Rheumatology (Oxford, England)96 citations
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients
2019American journal of ophthalmology88 citations
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
En bref
Dre Julie Hernandez consulte à CABINET DU DR JULIE HERNANDEZ, CABINET MEDICAL BELLEVUE — 330 AVENUE CHARLES DE GAULLE, 82000 Montauban. Adresses issues de l'Annuaire Santé (ANS).
Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Oui. Source : Assurance Maladie.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Montauban →Rhumatologues en Tarn-et-Garonne (82) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Montauban, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Association between bone health and cardiovascular events in a population-based cohort
2026Vector borne and zoonotic diseases (Larchmont, N.Y.)PubMed
Immunopathogenesis of Mayaro Virus-Induced Chronic Arthritis: From Inflammatory Pathways to Targeted Therapeutic Strategies
2026Cephalalgia : an international journal of headachePubMed
Impaired bone status in high frequency episodic or chronic migraine women: A case-control study with blood and densitometric parameters
2024PloS onePubMed
Cytokine and T cell responses in post-chikungunya viral arthritis: A cross-sectional study
2022Clinical and experimental rheumatologyPubMed
Long-term survival of renal transplantation in patients with lupus nephritis: experience from a single university centre
2020BiomoleculesPubMed
The Role of Chitosan and Graphene Oxide in Bioactive and Antibacterial Properties of Acrylic Bone Cements
2020Journal of clinical medicinePubMed
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study
2020Seminars in arthritis and rheumatismPubMed
Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients
2020Clinical and experimental rheumatologyPubMed
Long-term survival of lung transplantation for interstitial lung disease associated with connective tissue diseases: a study of 26 cases from a referral centre
2019Stem cell research & therapyPubMed
Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer
2022Therapeutic advances in musculoskeletal diseasePubMed
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
2021Seminars in arthritis and rheumatismPubMed
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
2020Rheumatology (Oxford, England)PubMed
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients
2020Clinical and experimental rheumatologyPubMed
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
2019Seminars in arthritis and rheumatismPubMed
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
2019American journal of ophthalmologyPubMed
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
2026European journal of internal medicinePubMed
Long-term vascular outcomes and biological predictors of thrombosis in systemic lupus erythematosus: a 10-year prospective cohort study
2026Oxford open immunologyPubMed
Exploring the role of gelsolin and high-density lipoproteins in autoimmune diseases: spotlight on rheumatoid arthritis and systemic lupus erythematosus
2025Patient preference and adherencePubMed
Impact of Systemic Lupus Erythematosus on Health-Related Quality of Life in Colombian Patients: A Cross-Sectional Analytical Study
2024ACR open rheumatologyPubMed
Exploring the Association Between Systemic Lupus Erythematosus and High-Density Lipoproteins: A Systematic Review and Meta-Analysis
2024Lupus science & medicinePubMed
Assessment of the role of high-density lipoproteins and their immunomodulatory activity in systemic lupus erythematosus immunopathology
2026Rheumatology (Oxford, England)PubMed
Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry
2022Therapeutic advances in musculoskeletal diseasePubMed
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
2021Seminars in arthritis and rheumatismPubMed
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
2020Clinical and experimental rheumatologyPubMed
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
2019Seminars in arthritis and rheumatismPubMed
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
2026Oxford open immunologyPubMed
Exploring the role of gelsolin and high-density lipoproteins in autoimmune diseases: spotlight on rheumatoid arthritis and systemic lupus erythematosus
2023BonePubMed
High incidence of clinical fragility fractures in postmenopausal women with rheumatoid arthritis. A case-control study
2021Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAPubMed
Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study
2020Rheumatology (Oxford, England)PubMed
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients
2019The Journal of rheumatologyPubMed
Relationship Between Insulin Sensitivity and β-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis
2022RMD openPubMed
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
2021Clinical and experimental rheumatologyPubMed
Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy
2019Arthritis & rheumatology (Hoboken, N.J.)PubMed
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
2024Scientific reportsPubMed
(18)F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis
2023RMD openPubMed
Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review
2020The Journal of rheumatologyPubMed
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
2021MaturitasPubMed
The atherogenic index of plasma is related to a degraded bone microarchitecture assessed by the trabecular bone score in postmenopausal women: The Camargo Cohort Study
2020PloS onePubMed
Prevalence and patterns of multimorbidity in the Jamaican population: A comparative analysis of latent variable models
2025Pediatric researchPubMed
Physiological and lifestyle determinants of bone mass in minority children/adolescents from the MetA-Bone Trial
2024European journal of pediatricsPubMed
Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections
2023 · Article
Agroecological measures in meadows promote honey bee colony development and winter survival
2021 · Article
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
2020 · Article
ColEval: Honeybee COLony Structure EVALuation for Field Surveys
2018 · Article
Measuring biological age to assess colony demographics in honeybees
2017 · Congrès
PROBEE : Impact des probiotiques sur la tolérance au Varroa et la santé des colonies d’abeilles domestiques
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.